The anticandidal properties of chlorinated 8-quinolinols

Mycologia

Volumn 88, Issue 4, 1996, Pages 651-654

  Lentz, David L ^a   Gershon, Herman ^a   Marini, Helen ^a   Gentry, Glenn A ^b  

^a NEW YORK BOTANICAL GARDEN   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

antifungal agents; baby hamster kidney (BHK) cells; Candida albicans; Candida tropicalis; chloro 8 quinolinols

Indexed keywords

BOVINAE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CRICETINAE; MAMMALIA;

EID: 0030442737     PISSN: 00275514     EISSN: None     Source Type: Journal    
DOI: 10.2307/3761162     Document Type: Article

References (18)

1. Armstrong, D. 1993. Treatment of opportunistic fungal infections. Clin. Infect. Dis. 16: 1-9.
2. Brack, A. 1962. Antimikrobielle Wirkung von 8-Hydroxychinolin-Derivaten, besonders von einigen neuen Estern. 13 Mitteilung über anti-mikrobielle Stoffe. Arzneimittel-Forschung 12: 133-144.
3. Drouhet, E. and B. Dupont. 1991. Candidosis in heroin addicts and AIDS: new immunologic data on chronic mucocutaneous candidosis. Pp. 61-72. In: Candida and candidamycosis. Eds., E. Tumbay, H. P. R. Seeliger, and O. Ang. Plenum Press, New York.
4. Fraser, R. and J. Creanor. 1974. Rapid and selective inhibition of RNA synthesis in yeast by 8-hydroxyquinoline. Eur. J. Biochem. 46: 67-73.
5. Gentry, G. A. and J. F. Aswell. 1975. Inhibition of herpes simplex virus replication by araT. Virology 65: 294-296.
6. Gershon, H. and D. D. Clarke. 1991. Improved syntheses of some monochloro- and monobromo-8-quinolinols. Monatsh. Chem. 122: 935-941.
7. _, _, and M. Gershon. 1994. Preparation and fungitoxcity of 3,6-dichloro and 3,6 dibromo-8-quinolinols. Monatsh. Chem. 125: 723-730.
8. _, M. W. McNeil, and A. T. Grefig. 1969. Reinvestigation of the action of N-halosuccinimides on bis (8-quinolinato)copper(II). J. Org. Chem. 34: 3268-3270.
9. Hawcraft, D., T. Hector, and F. Rowell. 1987. Quantitative bioassay. John Wiley, New York. 300 pp.
10. Jong, S.C. and M. J. Edwards (Eds.). 1990. American type culture collection catalogue of yeasts. 18th ed. American Type Culture Collection, Rockville, Maryland.
11. Kauffmann, C. A. 1994. Antifungal agents. Infect. Dis. Ther. 9: 441-452.
12. Krempl-Lambrecht, L. 1991. Factors of the pathogenicity of Candida albicans - a review. Pp. 49-54. In: Candida and candidamycosis. Eds., E. Tumbay, H. P. R. Seeliger, and O. Ang. Plenum Press, New York.
13. Pindborg, J. J. 1988. Oral candidiasis in HIV infection. Pp. 28-37. In: Perspectives on oral manifestations of AIDS. Eds., P. B. Robertson and J. S. Greenspan. PSG Publishing Co., Littleton, Massachusetts.
14. Poulter, R. T. M. 1995. Genetics of Candida species. Pp. 285-308. In: The Yeasts. Vol. 6, 2nd ed. Eds., A. H. Rose, A. E. Wheals, and J. S. Harrison. Academic Press, New York.
15. Rohde, W., P. Mikelens, J. Jackson, J. Blackman, J. Whitcher, and W. Levinson. 1976. Hydroxyquinolines inhibit ribonucleic acid-dependent deoxyribonucleic acid polymerase and inactivate Rous sarcoma virus and herpes simplex virus. Antimicrob. Agents Chemother. 10: 234-240.
16. Sternberg, S. 1994. The emerging fungal threat. Science 266: 1632-1634.
17. Sugar, A. M., C. A. Hitchcock, P. F. Troke, and M. Picard. 1995. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob. Agents Chemother. 39: 598-601.
18. Van Cutsem, J. 1994. Prophylaxis of Candida and Aspergillus infections with oral administration of itraconazole. Mycoses 37: 243-248.